Evidence map›Paper›PMID 25669604›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

The Vasopressin 1b Receptor Antagonist A-988315 Blocks Stress Effects on the Retrieval of Object-Recognition Memory.

Areg Barsegyan, Piray Atsak, Wilfried B Hornberger, Peer B Jacobson, Marcel M van Gaalen, Benno Roozendaal

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. The Biology of Vasopressin.Biomedicines · 2021
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Areg Barsegyan1] Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.
Piray Atsak1] Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.
Wilfried B HornbergerNeuroscience Research, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
Peer B JacobsonIntegrated Sciences and Technology, Imaging Research, AbbVie, North Chicago, IL, USA.
Marcel M van GaalenNeuroscience Research, AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany.
Benno Roozendaal1] Department of Cognitive Neuroscience, Radboud University Medical Centre, Nijmegen, The Netherlands [2] Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, The Netherlands.
AbbVie (Germany) · DERadboud University Nijmegen · NLAbbVie (United States) · USRadboud University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress-induced activation of the hypothalamo-pituitary-adrenocortical (HPA) axis and high circulating glucocorticoid levels are well known to impair the retrieval of memory. Vasopressin can activate the HPA axis by stimulating vasopressin 1b (V1b) receptors located on the pituitary. In the present study, we investigated the effect of A-988315, a selective and highly potent non-peptidergic V1b-receptor antagonist with good pharmacokinetic properties, in blocking stress effects on HPA-axis activity and memory retrieval. To study cognitive performance, male Sprague-Dawley rats were trained on an object-discrimination task during which they could freely explore two identical objects. Memory for the objects and their location was tested 24 h later. A-988315 (20 or 60 mg/kg) or water was administered orally 90 min before retention testing, followed 60 min later by stress of footshock exposure. A-988315 dose-dependently dampened stress-induced increases in corticosterone plasma levels, but did not significantly alter HPA-axis activity of non-stressed control rats. Most importantly, A-988315 administration prevented stress-induced impairment of memory retrieval on both the object-recognition and the object-location tasks. A-988315 did not alter the retention of non-stressed rats and did not influence the total time spent exploring the objects or experimental context in either stressed or non-stressed rats. Thus, these findings indicate that direct antagonism of V1b receptors is an effective treatment to block stress-induced activation of the HPA axis and the consequent impairment of retrieval of different aspects of recognition memory.

Indexed as

Adrenocorticotropic HormoneAnimalsAntidiuretic Hormone Receptor AntagonistsArginine VasopressinCorticosteroneDisease Models, AnimalExploratory BehaviorHumansMaleMemory DisordersMental RecallPiperazinesProtein BindingRatsRats, Sprague-DawleyReceptors, OxytocinA-988315Adrenocorticotropic HormoneAntidiuretic Hormone Receptor AntagonistsArginine VasopressinCorticosteronePiperazinesReceptors, OxytocinReceptors, VasopressinSulfonamidesTritium

Identifiers

PMID25669604
PMCPMC4839522
OpenAlexW2065878391

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.